TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01619111 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04517734 — Predictive Biomarker (PRD): ERFE mRNA
Genes: ERFE; C1QTNF15; CTRP15; FAM132B
Study NCT04353596 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00943774 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01476007 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00157157 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT01622842 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02181582 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT04164134 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study NCT04706949 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00967031 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00623324 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02558127 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00499681 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00499681 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01999452 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03385655 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT03392259 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02428101 — Predictive Biomarker (PRD): ABCG2 mRNA
Genes: ABCG2; ABCP; BCRP; BCRP1; MXR
Study NCT02644395 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02851589 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00943839 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00943839 — Predictive Biomarker (PRD): PPBP mRNA
Genes: PPBP; CTAP3; CXCL7; SCYB7; TGB1; THBGB1
Study NCT00943839 — Safety Biomarker (SAF): C-X-C motif chemokine 5
Genes: CXCL5; ENA78; SCYB5
Study NCT00943839 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00049166 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02217410 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT02907528 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT02907528 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT03045666 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03816904 — Predictive Biomarker (PRD): KCNN3 mRNA
Genes: KCNN3; K3
Study NCT02965365 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study NCT02695082 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03745911 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02855034 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT02855034 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT02855034 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT02855034 — Predictive Biomarker (PRD): UCHL1 mRNA
Genes: UCHL1
Study NCT01846351 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02889575 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01378780 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04321668 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02940418 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03882541 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04860076 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03207451 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT03170895 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT01075828 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01075828 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00171808 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00011258 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02275793 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT01631227 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00003619 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03528538 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01917721 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT00187564 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03053518 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study NCT01366937 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06220981 — Predictive Biomarker (PRD): OSCAR mRNA
Genes: OSCAR
Study NCT04100278 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03927521 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01623115 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT01623115 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00712140 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01076647 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01081600 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00452283 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT01998022 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01452373 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01337921 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT01451827 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT04454775 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04454775 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04454775 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT00821652 — Predictive Biomarker (PRD): CTAG1B mRNA
Genes: CTAG1A; CTAG; CTAG1; ESO1; LAGE2; LAGE2A; CTAG1B; LAGE2B
Study NCT02978755 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01734629 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01734629 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02933333 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02145559 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT02145559 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT02145559 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT02145559 — Predictive Biomarker (PRD): ULK1 mRNA
Genes: ULK1; KIAA0722
Study NCT03162562 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT03090139 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04762615 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT03927261 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT00879385 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00879385 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00879385 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study NCT00879385 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT01357226 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02544451 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02544451 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP
Study NCT03546621 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00623389 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT00860847 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00532493 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03896659 — Predictive Biomarker (PRD): CA3 mRNA
Genes: CA3
Study NCT05598073 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02443454 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03896412 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT03896412 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03896412 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT03896412 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00221026 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01508468 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03291535 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01253070 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT04395872 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT00223717 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04336436 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03347097 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03211767 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03211767 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03211767 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03211767 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04462380 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT01864746 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01864746 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01864746 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00935740 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT01378169 — Predictive Biomarker (PRD): PARP9 mRNA
Genes: PARP9; BAL; BAL1
Study NCT01378169 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01100827 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01100827 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00021736 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02714569 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02714569 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03313375 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00045227 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT04318626 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04318626 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT02377258 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04006548 — Predictive Biomarker (PRD): SNAP25 mRNA
Genes: SNAP25; SNAP
Study NCT02436993 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00079066 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00079066 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00490464 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03492242 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03492242 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT00039377 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00039377 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02361372 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02816775 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04303520 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04303520 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT03803631 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03976492 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT03976492 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT03976492 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02812693 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT04712695 — Monitoring Biomarker (MOI): Complement C7
Genes: C7
Study NCT04389151 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT01014208 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01165853 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00080353 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00080353 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00080353 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00080353 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01785888 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03818412 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03780218 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01698385 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02899936 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04723914 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04670341 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02429765 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study NCT02264704 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT04330638 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04330638 — Safety Biomarker (SAF): Interleukin 1
Study NCT04879550 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT01611038 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01386762 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02643303 — Predictive Biomarker (PRD): TLR3 mRNA
Genes: TLR3
Study NCT00626431 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01487681 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT01551043 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03522792 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT01827150 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02905253 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT01869816 — Predictive Biomarker (PRD): C1QTNF3 mRNA
Genes: C1QTNF3; CTRP3; UNQ753/PRO1484
Study NCT02294084 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02043769 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03947710 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04005573 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05113511 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02302365 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02935985 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02405403 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT02225210 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04088006 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00219102 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00202917 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03827083 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01871805 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00024557 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT03295396 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study NCT02549495 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00043472 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00043472 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT05439382 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT03015402 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT02491515 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04084717 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04084717 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03318588 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03318588 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT00524277 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00524277 — Predictive Biomarker (PRD): GP2 mRNA
Genes: GP2
Study NCT00524277 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00712361 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03832348 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04452630 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05030220 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT03279029 — Predictive Biomarker (PRD): MMRN1 mRNA
Genes: MMRN1; ECM; EMILIN4; GPIA*; MMRN
Study NCT04278859 — Predictive Biomarker (PRD): BTLA mRNA
Genes: BTLA
Study NCT03223662 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02601300 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02611336 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT01654666 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02408380 — Predictive Biomarker (PRD): TLR2 mRNA
Genes: TLR2; TIL4
Study NCT02408380 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT02408380 — Predictive Biomarker (PRD): CCR1 mRNA
Genes: CCR1; CMKBR1; CMKR1; SCYAR1
Study NCT02408380 — Predictive Biomarker (PRD): TLR2
Genes: TIL4; CD282
Study NCT02428192 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02854787 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03644303 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study NCT01876459 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT01598233 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02581631 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT03001076 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01147276 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00888927 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study NCT05502432 — Pharmacodynamic Biomarker (PDY): Ataxin-3
Genes: ATXN3; ATX3; MJD; MJD1; SCA3
Study NCT04104828 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04104828 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04113655 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02894762 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00005007 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01269515 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00296400 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02673073 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01887886 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01887886 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02078908 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00511706 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00511706 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00511706 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03781310 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02794922 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00985127 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT03965351 — Predictive Biomarker (PRD): TRPV2 mRNA
Genes: TRPV2; VRL
Study NCT03419481 — Predictive Biomarker (PRD): ZFP36 mRNA
Genes: ZFP36; G0S24; NUP475; RNF162A; TIS11A; TTP
Study NCT01308385 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT01391260 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01364103 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04308668 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00394862 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03576729 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT02008877 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT01557114 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT03595917 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7